Search

everythinglearnresearchcommunity

for

Search:↓

Low prolactin in young women may increase heart and metabolism risks.

Balding people may have higher heart disease risk.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Modern science supports the use of some Ayurvedic plants for health, as ancient practices suggested.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Pannexin 3 is important for bone formation and the development of bone cells.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Adults with certain skin conditions may have higher levels of inflammation in their body.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.